110 related articles for article (PubMed ID: 9128977)
1. Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
Heidenreich A; Sesterhenn IA; Moul JW
Cancer; 1997 May; 79(9):1641-5; discussion 1646. PubMed ID: 9128977
[No Abstract] [Full Text] [Related]
2. Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
Herr HW
Cancer; 1998 Jan; 82(1):230-2. PubMed ID: 9428504
[No Abstract] [Full Text] [Related]
3. MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.
Albers P; Bierhoff E; Neu D; Fimmers R; Wernert N; Müller SC
Cancer; 1997 May; 79(9):1710-6. PubMed ID: 9128986
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
Heidenreich A; Schenkmann NS; Sesterhenn IA; Mostofi FK; McCarthy WF; Heidenreich B; Moul JW
J Urol; 1997 Aug; 158(2):620-5. PubMed ID: 9224380
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
[TBL] [Abstract][Full Text] [Related]
6. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.
Albers P; Orazi A; Ulbright TM; Miller GA; Haidar JH; Donohue JP; Foster RS
Mod Pathol; 1995 Jun; 8(5):492-7. PubMed ID: 7545814
[TBL] [Abstract][Full Text] [Related]
8. Staging and prognostic factors in testicular cancer.
Lawton AJ; Mead GM
Semin Surg Oncol; 1999 Dec; 17(4):223-9. PubMed ID: 10588850
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases].
Chraibi Y; Culine S; Terrier-Lacombe MJ; Kramar A; Kattan J; Droz JP
Bull Cancer; 1994 Apr; 81(4):311-7. PubMed ID: 7703548
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation.
Chin JL; Banerjee D; Kadhim SA; Kontozoglou TE; Chauvin PJ; Cherian MG
Cancer; 1993 Nov; 72(10):3029-35. PubMed ID: 8221570
[TBL] [Abstract][Full Text] [Related]
11. Double immunolabeling by the RBM and the PLAP markers for identifying intratubular (in situ) germ cell neoplasia of the testis.
Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Elliott DJ; Kula K; Slowikowska-Hilczer J; Maymon BB
Int J Surg Pathol; 2003 Jan; 11(1):17-20. PubMed ID: 12598912
[TBL] [Abstract][Full Text] [Related]
12. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
[TBL] [Abstract][Full Text] [Related]
13. New prognostic factors for stage I testicular cancer: but will they make it to broadway?
Raghavan D
J Clin Oncol; 2003 Nov; 21(22):4075-6. PubMed ID: 14559887
[No Abstract] [Full Text] [Related]
14. Extratesticular extension of germ cell tumors preferentially occurs at the hilum.
Dry SM; Renshaw AA
Am J Clin Pathol; 1999 Apr; 111(4):534-8. PubMed ID: 10191775
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis.
Datta MW; Renshaw AA; Dutta A; Hoffman MA; Loughlin KR
Mod Pathol; 2000 Jun; 13(6):667-72. PubMed ID: 10874672
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of stage I germ cell tumor of the testis].
Rubio Briones J; Solsona Narbón E
Arch Esp Urol; 2000; 53(6):491-9. PubMed ID: 11002517
[TBL] [Abstract][Full Text] [Related]
17. Germ cell tumour as a diagnostic pitfall of metastatic carcinoma.
Shek TW; Yuen ST; Luk IS; Wong MP
J Clin Pathol; 1996 Mar; 49(3):223-5. PubMed ID: 8675733
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of stage I germ cell tumors of the testis].
Santomé Couto L; Tabernero Caturla JM; Villavicencio Mavrich H; Valentí Moreno V
Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in low-stage nonseminomatous testicular cancer.
Moul JW; Heidenreich A
Oncology (Williston Park); 1996 Sep; 10(9):1359-68, 1374; discussion 1377-8. PubMed ID: 8882926
[TBL] [Abstract][Full Text] [Related]
20. The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.
Ulbright TM; Orazi A; de Riese W; de Riese C; Messemer JE; Foster RS; Donohue JP; Eble JN
Mod Pathol; 1994 Jan; 7(1):64-8. PubMed ID: 7909155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
